These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38507608)

  • 81. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience.
    Pabla BS; Alex Wiles C; Slaughter JC; Scoville EA; Dalal RL; Beaulieu DB; Schwartz DA; Horst SN
    Dig Dis Sci; 2022 Jul; 67(7):3129-3137. PubMed ID: 34268660
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Changing face of care for patients with moderate to severe inflammatory bowel disease: the role of specialist nurses in the governance of anti-TNF prescribing.
    Connell WR; Samyue T; Gibson PR; Lachal S; Moore GT; Macrae FA; Van Langenberg DR
    Intern Med J; 2015 Nov; 45(11):1161-6. PubMed ID: 26178007
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
    Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
    BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial.
    Del Hoyo J; Nos P; Faubel R; Muñoz D; Domínguez D; Bastida G; Valdivieso B; Correcher M; Aguas M
    J Med Internet Res; 2018 Nov; 20(11):e11602. PubMed ID: 30482739
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.
    Franceschi M; Scarcelli C; Niro V; Seripa D; Pazienza AM; Pepe G; Colusso AM; Pacilli L; Pilotto A
    Drug Saf; 2008; 31(6):545-56. PubMed ID: 18484788
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
    Collen LV; Mitsialis V; Kim DY; Bresnahan M; Yang J; Tuthill M; Combs A; Barends J; Field M; Liu E; Bearup R; Okoroafor I; Klein C; Muise AM; Bousvaros A; Ouahed J; Snapper SB
    Inflamm Bowel Dis; 2024 Sep; 30(9):1443-1453. PubMed ID: 37847820
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.
    Lobatón T; Ferrante M; Rutgeerts P; Ballet V; Van Assche G; Vermeire S
    Aliment Pharmacol Ther; 2015 Aug; 42(4):441-51. PubMed ID: 26104047
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.
    El Hajj MS; Kaddoura R; Abu Yousef SEA; Orabi B; Awaisu A; AlYafei S; Shami R; Mahfoud ZR
    Int J Clin Pharm; 2023 Jun; 45(3):630-640. PubMed ID: 36795303
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Patterns in counselling services provided at Saudi Ministry of Health medication counselling clinics - Reasons for referrals and subjects discussed: A cross-sectional study.
    Salhia H; Mutlaq A; Alshaiban A; Alsaleh A; Alzahrani R; Alshennawi M
    Saudi Pharm J; 2023 Jul; 31(7):1157-1166. PubMed ID: 37287507
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of a medicines management model on medication-related readmissions in older patients admitted to a medical acute admission unit-A randomized controlled trial.
    Graabaek T; Hedegaard U; Christensen MB; Clemmensen MH; Knudsen T; Aagaard L
    J Eval Clin Pract; 2019 Feb; 25(1):88-96. PubMed ID: 30088321
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors.
    Asio L; Nasasira M; Kiguba R
    Ther Adv Drug Saf; 2023; 14():20420986231188842. PubMed ID: 37529762
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial.
    Hall CL; Fominaya CE; Gebregziabher M; Milfred-LaForest SK; Rife KM; Taber DJ
    JMIR Res Protoc; 2019 Oct; 8(10):e13821. PubMed ID: 31573933
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).
    Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM
    Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial.
    Gonzales HM; Fleming JN; Gebregziabher M; Posadas Salas MA; McGillicuddy JW; Taber DJ
    Ann Pharmacother; 2022 Jun; 56(6):685-690. PubMed ID: 34496669
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
    Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M
    Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.